Apolipoprotein E genotyping and phenotyping in type II diabetes mellitus patients with hypertriglyceridemia

被引:10
作者
Kim, JH
Lee, EJ
Kwon, OH
机构
[1] YONSEI UNIV,COLL MED,YONGDONG SEVERANCE HOSP,DEPT INTERNAL MED,SEOUL 135270,SOUTH KOREA
[2] YONSEI UNIV,COLL MED,DEPT CLIN PATHOL,SEOUL 120752,SOUTH KOREA
[3] WASHINGTON UNIV,SCH MED,LIPID RES CTR,ST LOUIS,MO 63110
关键词
apolipoproteins E; polymorphism; type II diabetes mellitus; genotypes; phenotypes; isoelectric focusing; hypertriglyceridemia; gene frequency; restriction fragment length polymorphisms;
D O I
10.1016/S0009-9120(96)00130-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: We investigated the possible effect of apolipoprotein E (ape E) polymorphism on hypertriglyceridemia in type II diabetes mellitus (DM) patients by both apo E genotyping and phenotyping methods. Design and Methods: Eighty Korean type II DM patients were evaluated. Restriction isotyping after DNA amplification was used for apo E genotyping. The isoelectric focusing of neuraminidase-treated sera followed by immunoblotting was used for apo E phenotyping. Results: The concordant rate between apo E genotyping and phenotyping was 96.3%. Apo E genotype frequencies for all 77 concordant cases were as follows: 72.7% for epsilon 3/3; 16.9% for epsilon 3/4; 7.8% for epsilon 2/3; 1.3% for epsilon 2/4, 1.3% for epsilon 4/4; and 0% for epsilon 2/2. There were no significant differences in apo E genotype frequencies between hypertriglyceridemic (n = 42) and normotriglyceridemic (n = 35) groups. Conclusions: Our findings could not support the association between apo E polymorphism and hypertriglyceridemia among type II DM patients.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 35 条
[1]   DNA POLYMORPHISMS OF APOLIPOPROTEIN A-I/C-III AND INSULIN GENES IN FAMILIAL HYPERTRIGLYCERIDEMIA AND CORONARY HEART-DISEASE [J].
AALTOSETALA, K ;
KONTULA, K ;
SANE, T ;
NIEMINEN, M ;
NIKKILA, E .
ATHEROSCLEROSIS, 1987, 66 (1-2) :145-152
[2]   METABOLISM OF CHOLESTEROL AND PLASMA TRIGLYCERIDES IN NON-KETOTIC DIABETES-MELLITUS [J].
ABRAMS, JJ ;
GINSBERG, H ;
GRUNDY, SM .
DIABETES, 1982, 31 (10) :903-910
[3]  
[Anonymous], 1989, MOL CLONING LAB MANU
[4]   LIPOPROTEIN RECEPTORS IN THE LIVER - CONTROL SIGNALS FOR PLASMA-CHOLESTEROL TRAFFIC [J].
BROWN, MS ;
GOLDSTEIN, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (03) :743-747
[5]   REVERSIBLE ABNORMALITIES IN POSTHEPARIN LIPOLYTIC-ACTIVITY DURING LATE PHASE OF RELEASE IN DIABETES-MELLITUS (POSTHEPARIN LIPOLYTIC-ACTIVITY IN DIABETES) [J].
BRUNZELL, JD ;
PORTE, D ;
BIERMAN, EL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (10) :1123-1137
[6]   APOLIPOPROTEIN-E POLYMORPHISM MODIFIES RELATION OF HYPERINSULINEMIA TO HYPERTRIGLYCERIDEMIA [J].
DESPRES, JP ;
VERDON, MF ;
MOORJANI, S ;
POULIOT, MC ;
NADEAU, A ;
BOUCHARD, C ;
TREMBLAY, A ;
LUPIEN, PJ .
DIABETES, 1993, 42 (10) :1474-1481
[7]   MOLECULAR SCREENING OF THE LIPOPROTEIN-LIPASE GENE IN HYPERTRIGLYCERIDEMIC MEMBERS OF FAMILIAL NONINSULIN-DEPENDENT DIABETES-MELLITUS FAMILIES [J].
ELBEIN, SC ;
YEAGER, C ;
KWONG, LK ;
LINGAM, A ;
INOUE, I ;
LALOUEL, JM ;
WILSON, DE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05) :1450-1456
[8]   APOLIPOPROTEIN-E ALLELE FREQUENCIES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS WITH HYPERTRIGLYCERIDEMIA (TYPE-IIB, TYPE-III, TYPE-IV, AND TYPE-V HYPERLIPOPROTEINEMIA) [J].
ETO, M ;
WATANABE, K ;
MAKINO, I ;
ISHII, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (08) :776-780
[9]   ABNORMAL INVIVO METABOLISM OF APOLIPOPROTEIN-E4 IN HUMANS [J].
GREGG, RE ;
ZECH, LA ;
SCHAEFER, EJ ;
STARK, D ;
WILSON, D ;
BREWER, HB .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (03) :815-821
[10]   GENOTYPING COMPARED WITH PROTEIN PHENOTYPING OF THE COMMON APOLIPOPROTEIN-E POLYMORPHISM [J].
HANSEN, PS ;
GERDES, LU ;
KLAUSEN, IC ;
GREGERSEN, N ;
FAERGEMAN, O .
CLINICA CHIMICA ACTA, 1994, 224 (02) :131-137